Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 16
Submit an article Journal homepage
739
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

Empagliflozin for the treatment of type 2 diabetes

Vidhya JahagirdarHeart of England NHS Foundation Trust, Department of Diabetes and Endocrinology, Birmingham, UK
, MRCP &
Anthony H BarnettUniversity of Birmingham and Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital, Diabetes Centre, Birmingham B9 5SS, UK+44 121 424 3587; +44 121 424 0593; [email protected]
, MD
Pages 2429-2441 | Published online: 10 Oct 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Brian Tomlinson, Miao Hu, Yuzhen Zhang, Paul Chan & Zhong-Min Liu. (2017) Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 211-223.
Read now
Jingbo Hu, Ping Zou, Shuo Zhang, Minzhi Zhou & Xueying Tan. (2016) Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes. Expert Opinion on Pharmacotherapy 17:18, pages 2471-2477.
Read now
Matthew R. Weir. (2016) The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors. Postgraduate Medicine 128:3, pages 290-298.
Read now

Articles from other publishers (9)

Ana Karen Estrada, Timoteo Delgado-Maldonado, Edgar E. Lara-Ramírez, Ana Verónica Martínez-Vázquez, Eyra Ortiz-Pérez, Alma D. Paz-González, Debasish Bandyopadhyay & Gildardo Rivera. (2022) Recent Advances in the Development of Type 2 Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 2 Diabetes Mellitus. Mini-Reviews in Medicinal Chemistry 22:4, pages 586-599.
Crossref
Xue-Song Gu, Ying Xiong, Fan Yang, Na Yu, Pu-Cha Yan, Jian-Hua Xie & Qi-Lin Zhou. (2022) Enantioselective Hydrogenation toward Chiral 3-Aryloxy Tetrahydrofurans Enabled by Spiro Ir-PNN Catalysts Containing an Unusual 5-Substituted Chiral Oxazoline Unit. ACS Catalysis 12:4, pages 2206-2211.
Crossref
Tejas Wattamwar, Ashish Mungantiwar, Supriya Halde & Nancy Pandita. (2019) Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography–mass spectrometry and application to pharmacokinetics. European Journal of Mass Spectrometry 26:2, pages 117-130.
Crossref
Mizhgona Umedzhonovna Sharofova, Shoista Samarovna Sagdieva & Salomudin Dzhabbor Yusuf. (2019) DIABETES MELLITUS: THE MODERN STATE OF THE ISSUE (PART 2). AVICENNA BULLETIN 21:4, pages 661-674.
Crossref
Abdul Malik Thalha, Sanjiv Mahadeva, Alexander Tong Boon Tan & Kein Seong Mun. (2018) Kombiglyze (metformin and saxagliptin)-induced hepatotoxicity in a patient with non-alcoholic fatty liver disease. JGH Open 2:5, pages 242-245.
Crossref
Andrew J. Krentz & Alan J. Sinclair. 2017. Diabetes in Old Age. Diabetes in Old Age 298 322 .
Leonie van Meer, Marloes van Dongen, Matthijs Moerland, Marieke de Kam, Adam Cohen & Jacobus Burggraaf. (2017) Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects. Pharmacology Research & Perspectives 5:1, pages e00292.
Crossref
L. van Meer, M. Moerland, M. van Dongen, B. Goulouze, M. de Kam, E. Klaassen, A. Cohen & J. Burggraaf. (2016) Renal Effects of Antisense-Mediated Inhibition of SGLT2. Journal of Pharmacology and Experimental Therapeutics 359:2, pages 280-289.
Crossref
Abd A. Tahrani, Anthony H. Barnett & Clifford J. Bailey. (2016) Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature Reviews Endocrinology 12:10, pages 566-592.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.